Biotechnology in N.J. shows growth despite lack of startup money
News | 07 August 2012
Biotechnology is a growing field in New Jersey. It is showing growth at a time when New Jersey's long-standing pharmaceutical industry is shrinking. A recent poll of N.J. biotech companies showed that, despite losses by Big Pharma, New Jersey continues ...
Click on the link to read the full article at newjerseynewsroom.com
(This link will open in a new window)
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
